Induction of pluripotent stem cells from fibroblast cultures
By Kazutoshi Takahashi, K. Okita, M. Nakagawa, S. Yamanaka. Nature Protocols, 2007
1,059 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/4ce6a28609c225ed928bf585391995b985860709
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Jennifer Nichols
- Austin G Smith
- José C. R. Silva
- T. Theunissen
- Ornella Barrandon
- Sheng Ding
- Hongyan Zhou
- Janghwan Kim
Citations in the corpus
- Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition (2008, methodology): “We first infected mouse embryo fibroblasts (MEFs) with retroviruses harbouring the reprogramming factors Oct4, Sox2, c-MycT58, and Klf4 exactly as described [2,12].”
- Alzheimer’s disease: experimental models and reality (2017, background): “The development of induced pluripotent stem cells (iPSCs) addresses this limitation [153].”
- Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy (2011, methodology): “Retroviruses encoding Oct4 , Sox2 , Klf4 and c-Myc were individually packaged in PLAT-E cells using pMXs-based vectors (Addgene) and infections were carried out as previously describe”
- Gene therapy clinical trials worldwide to 2012 – an update (2013, methodology): “that somatic cells can be reprogrammed to a state of pluripotency through the ectopic expression of as little as four transcription factors [75,76] has the potential to be a powerful tool for both gene and cellular therapies and to revolutionise”